CAS No. |
145022-92-0 |
|---|---|
英文名称 |
sodium 2-((R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonate |
别名 |
Tauro-β-muricholic acid sodium;T-βMCA sodium;Tauro-β-muricholic Acid sodium salt;2-[[(3α,5β,6β,7β)-3,6,7-trihydroxy-24-oxocholan-24-yl]amino]-ethanesulfonicacid,monosodiumsalt;Tauro-β-Muricholic Acid-[d5] Sodium Salt;D4-Tauro-β-muricholic Acid Sodium Salt;Tauro-muricholic Acid (sodium salt) |
标准英文名 |
sodium 2-((R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonate |
分子式 |
C26H44NNaO7S |
分子量 |
537.70 |
精确分子量 |
537.27 |
SMILES |
C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@@H](O)[C@@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.[Na+] |
标准SMILES |
[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1[C@H](O)[C@@H]3O |
用途 |
Tauro-β-muricholic acid sodium is used as a competitive and reversible farnesoid X receptor (FXR) antagonist (IC50 = 40 μM); it inhibits FXR reporter activity in colorectal cancer (CRC) cell lines (e.g., HT29, EC50 ~10 μM); enhances WNT signaling in a dose-dependent manner in HT29 and HCT116 cells; induces proliferation and DNA damage in Lgr5+ cells; promotes colorectal cancer progression in vivo, mimicking the effects of a high-fat diet (HFD); increases serum levels of pro-inflammatory cytokines such as IFN-γ, IL-6, and IL-17; and accelerates intestinal and colonic tumor growth while impairing intestinal integrity in APCmin/+ mouse models. |
InChIKey |
NYXROOLWUZIWRB-GPHZYVDLSA-M |
|
|
评论 |
|---|